334 related articles for article (PubMed ID: 18245052)
1. Commentary: Addressing corporate influence through ethical guidelines.
Greenland S
Int J Epidemiol; 2008 Feb; 37(1):57-9; discussion 65-8. PubMed ID: 18245052
[No Abstract] [Full Text] [Related]
2. [Clinical practice and pharmaceutical industry: an always difficult relationship].
Mastai R
Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
[No Abstract] [Full Text] [Related]
3. Medicine and the pharmaceutical industry: a call to action.
Stiles MM; Barrett B
Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
[No Abstract] [Full Text] [Related]
4. Radiology and industry: can this relationship be saved?
Forman HP
J Am Coll Radiol; 2006 May; 3(5):333-4. PubMed ID: 17412076
[No Abstract] [Full Text] [Related]
5. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
6. Industry relations with emergency medicine graduate medical education programs.
Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
[TBL] [Abstract][Full Text] [Related]
7. Medtronic "fusiongate".
Boehm FH
Surg Neurol; 2006 Nov; 66(5):551. PubMed ID: 17084214
[No Abstract] [Full Text] [Related]
8. Getting drug money out of doctors' offices...
Nagarkar PA
Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(1):13-7. PubMed ID: 20178201
[No Abstract] [Full Text] [Related]
9. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
10. Re "Getting drug money out of doctors' offices".
Jacobs J
Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):50; author reply 50-1. PubMed ID: 20690557
[No Abstract] [Full Text] [Related]
11. Commentary: Lack of scientific influences on epidemiology.
Phillips CV
Int J Epidemiol; 2008 Feb; 37(1):59-64; discussion 65-8. PubMed ID: 18245053
[No Abstract] [Full Text] [Related]
12. Banning pens and pads misses the main point.
Terry SF; Burke W
Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
[No Abstract] [Full Text] [Related]
13. [The influence of the pharmaceutical industry on treatment guidelines].
Kramers C; Wuis E; Schouwenberg B
Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
[No Abstract] [Full Text] [Related]
14. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
Alpert JS
Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
[No Abstract] [Full Text] [Related]
15. The medical profession and the pharmaceutical industry: when will we open our eyes?
Breen KJ
Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
[TBL] [Abstract][Full Text] [Related]
16. [Strategies for drug promotion].
Polonuer JL
Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
[No Abstract] [Full Text] [Related]
17. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
Moynihan R
BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
[TBL] [Abstract][Full Text] [Related]
18. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
19. Do ethical Guidelines make a difference to decision-making?
Osborn M; Day R; Komesaroff P; Mant A
Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
[TBL] [Abstract][Full Text] [Related]
20. The death of common sense.
Trachtman H
Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
